CMLT20003, Moore, NRG-GY022, Malignant Solid Neoplasm, CarboplatinResearch Question:
How well does iohexol, a contrast agent, work in helping doctors calculate the dose
of carboplatin given to patients with cancer?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This trial studies how well iohexol works in helping doctors calculate the dose of
carboplatin given to patients with cancer. Drugs used in chemotherapy, such as carboplatin,
work in different ways to stop the growth of tumor cells, either by killing the cells,
by stopping them from dividing, or by stopping them from spreading. Understanding
how to best calculate the dose of carboplatin given to patients with cancer may help
doctors learn how to improve the use of carboplatin in the future.
Study Reference #: CMLT20003
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search